Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06562634Enrolling by invitation
Trial of bupivacaine hydrochloride 0.75% injection and Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Total morphine consumption during the 1st 24 h postoperative. Started Mar 2025; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06562634.